AIM ImmunoTech Inc. · AMEX:AIM

Equels Thomas K bought 38,000 AIM ImmunoTech Inc. shares (Form 4)

Traded Nov 16, 2026 · Filed Nov 17, 2026

On Nov 16, 2026, Equels Thomas K (Director, CEO & President) bought 38,000 AIM ImmunoTech Inc. shares at US$0.14 for US$5,130, leaving 366,095 shares. Filed Nov 17, 2026 (Form 4).

Bought
38,000 shares
Price
US$0.14
Value
US$5,130
Holding after
366,095 shares
Trading plan
No
Role
Director, CEO & President

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 16, 2026Common StockBuy38,000US$0.14366,095Direct

Source

Download original · View original at SEC

Related